CONNECT WITH US
HealthTech

HealthTech

A vaccine for acne? Scientists are working on it

Medical Xpress logo

Published on

Add as a preferred source on Google
A vaccine for acne? Scientists are working on it

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Acne affects around 85% of adolescents and can persist well into adulthood. For some, this means occasional pimples. For others, it can mean years of painful inflammation, scarring and lost confidence.

Could a vaccine prevent or reduce that suffering? While we tend to think of vaccination as a tool to stop infectious diseases, scientists are working on a potential shot for acne.

Acne is an inflammatory disorder of the hair follicles and the oil glands attached to them on our skin.

One bacterium, Cutibacterium acnes, is particularly relevant here. C. acnes normally lives on healthy skin, but different strains produce different chemical proteins that in turn have various effects on the skin.

So how does this lead to acne? Think of the hair follicle as a pressure cooker. The follicular opening (pore) can become blocked by a mixture of dead skin cells and oil—like closing the lid. Hormones increase oil production, and the trapped oil and skin cells build up inside the follicle, causing it to expand.

This creates an environment where C. acnes bacteria thrive. The bacteria produce substances that irritate the follicle and trigger inflammation, an immune response leading to redness and swelling. (One of these substances is called CAMP2—we'll come back to this one later.)

This inflammation can weaken the follicle wall, sometimes causing it to rupture and spill its contents into the surrounding skin.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.